| Species |
Human |
| Protein Construction |
| His |
Galectin 9/LGALS9 (Ala2-Thr323)
Accession # O00182-2 |
| N-term |
C-term |
|
| Purity |
> 95% as determined by Bis-Tris PAGE |
| Endotoxin Level |
Less than 1EU per μg by the LAL method. |
| Expression System |
HEK293 |
| Theoretical Molecular Weight |
36.9 kDa |
| Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 50-65 kDa based on Bis-Tris PAGE result. |
| Formulation |
Lyophilized from 0.22μm filtered solution in 20 mM MOPS, 50 mM NaCl, 1 mM EDTA, 2 mM DTT (pH 7.4). |
| Reconstitution |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
| Target Background |
Galectin-9 is a secreted carbohydrate-binding protein with two lectin domains connected by a linker region.Galectins are a family of proteins defined by their binding specificity for β-galactoside sugars, such as N-acetyllactosamine , which can be bound to proteins by either N-linked or O-linked glycosylation. |
| Synonyms |
Ecalectin; GAL9; gal-9; Galectin9; Galectin-9; HUAT; LGALS9; LGALS9A; MGC117375; MGC125973; MGC125974 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
